Phosphorylation of the NADPH Oxidase Component p67PHOX by ERK2 and P38MAPK: Selectivity of Phosphorylated Sites and Existence of an Intramolecular Regulatory Domain in the Tetratricopeptide-Rich Region
- 25 March 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 42 (15) , 4520-4526
- https://doi.org/10.1021/bi0205754
Abstract
P67PHOX, a cytosolic component of the NADPH oxidase complex, is phosphorylated during neutrophil activation by several agonists. The intracellular signaling pathways leading to its phosphorylation in neutrophils may involve a PKC-dependent pathway and a PKC-independent pathway. Here, we analyzed p67PHOX phosphorylation by ERK2 and p38MAPK. Both ERK2 and p38MAPK phosphorylated p67PHOX in vitro, with similar Km values (10 and 9 μM, respectively). Phosphopeptide mapping indicated that ERK2 and p38MAPK phosphorylate different subgroups of peptides. Using truncated forms of p67PHOX, we found that the major phosphorylation target site of ERK2 was located in the N-terminal fragment (1−243), while the major phosphorylation target sites of p38MAPK were located in the C-terminal fragment (244−526). Furthermore, an additional peptide, which was not phosphorylated in the intact protein, appeared to be phosphorylated in the isolated C-terminal fragment (aa 244−526). This site may not thus be accessible in the intact protein. Indeed, incubation of the C-terminal fragment (244−526) with different N-terminal fragments (1−243, 1−210, or 1−199) containing the tetratricopeptide-rich region prevented phosphorylation of this C-terminal fragment. ERK1/2 and p38MAPK are also involved in p67PHOX phosphorylation in intact neutrophils. Indeed, PD98059 and SB203580, two selective inhibitors of MEK1/2 and p38MAPK, respectively, inhibited p67PHOX phosphorylation in fMLP- and PMA-stimulated neutrophils, with additive effects, thus suggesting that they also target different sites in vivo. Furthermore, the major peptides phosphorylated by ERK2 and p38MAPK in vitro were also phosphorylated in fMLP-stimulated neutrophils. Taken together, these results suggest not only that p67PHOX is phosphorylated by ERK2 and p38MAPK in vitro and in intact neutrophils on several selective sites but also that a C-terminal phosphorylation site may become accessible after a conformational change of the protein.Keywords
This publication has 17 references indexed in Scilit:
- The Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway Is Involved in formyl-Methionyl-Leucyl-Phenylalanine-Induced p47phox Phosphorylation in Human NeutrophilsThe Journal of Immunology, 2000
- Arachidonic Acid and Phosphorylation Synergistically Induce a Conformational Change of p47 to Activate the Phagocyte NADPH OxidaseJournal of Biological Chemistry, 2000
- The major phosphorylation site of the NADPH oxidase component p67phox is Thr233Biochemical Journal, 1999
- Phosphorylation of the Respiratory Burst Oxidase Subunit p47 as Determined by Two-dimensional Phosphopeptide MappingJournal of Biological Chemistry, 1996
- The Rac Target NADPH Oxidase p67 Interacts Preferentially with Rac2 Rather Than Rac1Published by Elsevier ,1996
- FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase.Journal of Clinical Investigation, 1994
- Activation of NADPH oxidase of human neutrophils involves the phosphorylation and the translocation of cytosolic p67phoxBiochemical Journal, 1993
- Chronic Granulomatous Disease: The Solving of a Clinical Riddle at the Molecular LevelClinical Immunology and Immunopathology, 1993
- The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.Journal of Clinical Investigation, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970